David Fiorentino is a Dermatology physician affiliated with Stanford University. OpenAlex indexes 248 publications with 24,493 citations (h-index 67); ClinicalTrials.gov lists 2 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Dermatology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
300 Pasteur Dr
Stanford, CA 943052200
Telephone
650-723-4000Provider last certified this registry record 16 Apr 2024.
Clinical trials
- Study of KYV-101 Anti-CD19 CAR T Therapy in Adult Dermatomyositis
Sponsor: Stanford University
- Safety and Efficacy Study of Humira in Treatment of Pyoderma Gangrenosum
Sponsor: Wright State University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20253 payments
- Legend Biotech USA Inc.Program year20251 payment
- UCB SAProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
41.4%Corticosteroid41.4%Prednisone100%Part D<11 patientsCancer & immunology
32.8%Folate Analog Metabolic Inhibitor21.6%Methotrexate100%Part D<11 patientsThalidomide Analog11.2%Lenalidomide100%Part D<11 patientsSensory organs
13.8%Corticosteroid13.8%Clobetasol Propionate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2006–2007 per NIH RePORTER. The latest:
- MULTIPLE DOSES OF TRX1 (ANTI-CD4 MAB) WHEN ADMINISTERED BY INTRAVENOUS INFUSION
Stanford University
FY2007$14,628M01RR000070 - RITUXIMAB IN THE TREATMENT OF PATIENTS WITH DERMATOMYOSITIS
Stanford University
FY2007$8,193M01RR000070 - RITUXIMAB IN THE TREATMENT OF PATIENTS WITH DERMATOMYOSITIS
Stanford University
FY2006$27,131M01RR000070
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Renumathy Dhanasekaran, MD, PhD
Stanford University
Euan Ashley, MD
Stanford University
Sarah Donaldson, MD
Stanford University
Peter Fitzgerald, MD
Stanford University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”